Every SEC Form 3/4/5 on record for this filer (CIK 1835498) — 1 issuer, 13 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| VVOS | Vivos Therapeutics, Inc. | Chief Executive Officer · Director | 2020-12-10 → 2024-11-27 | 16 | $123,531 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| VVOS | 2023-06-20 | Buy | 14,000 | $0.53 | $7,420 | 86,521 |
| VVOS | 2023-06-16 | Buy | 10,000 | $0.54 | $5,400 | 67,521 |
| VVOS | 2023-06-16 | Buy | 5,000 | $0.53 | $2,650 | 72,521 |
| VVOS | 2023-06-15 | Buy | 21 | $0.50 | $11 | 57,521 |
| VVOS | 2023-06-14 | Buy | 10,000 | $0.49 | $4,900 | 57,500 |
| VVOS | 2022-12-23 | Buy | 20,000 | $0.50 | $10,000 | 47,500 |
| VVOS | 2022-06-01 | Buy | 4,000 | $1.83 | $7,320 | 27,500 |
| VVOS | 2022-05-31 | Buy | 8,000 | $2.03 | $16,240 | 23,500 |
| VVOS | 2021-09-21 | Buy | 5,000 | $4.31 | $21,550 | 15,500 |
| VVOS | 2021-08-17 | Buy | 5,000 | $3.00 | $15,000 | 10,500 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.
